A wearable micro-infusion pump called D-mine has been developed by Sensile Medical for Ever Pharma.
The pump recently received CE certification and is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease, aiming to give patients greater independence in their day-to-day lives.
Georges Kahwati, general manager at Ever Pharma said: “In developing the Ever Pharma D-mine pump for treating Parkinson’s disease, we have completed a very challenging project with a tough set of requirements. This product signals clearly that Ever Pharma is committed to focusing on the needs of patients and providing them with customised solutions and innovative medical products.”
The D-mine pump is used to administer apomorphine in the advanced stages of Parkinson’s treatment. Simple handling, safety, and ease of use were the main aims behind the development. The compact design is down to Sensile Medical’s special micro-rotation pump technology and is straightforward to use thanks to an intuitive menu interface.
Derek Brandt, CEO of Sensile Medical said: “With Ever Pharma’s successful market launch, Sensile has delivered an ambitious project with highly innovative user requirements. Parkinson’s patients now have an innovative solution at their fingertips. Our integrated pump technology is already proving its worth in other treatment areas.”
